Inflammatory Bowel Disease: From Bench to BedsideStephan R. Targan, Fergus Shanahan, Loren C. Karp Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effectiveness of a team approach of basic scientists and clinician investigators in this field. |
Contents
I | v |
II | 1 |
III | 3 |
| 5 | |
V | 21 |
VI | 67 |
VII | 101 |
VIII | 121 |
XXXVI | 495 |
XXXVII | 523 |
XXXVIII | 555 |
XXXIX | 573 |
XL | 587 |
XLI | 603 |
XLII | 629 |
XLIII | 641 |
Other editions - View all
Inflammatory Bowel Disease: From Bench to Bedside Stephan R. Targan,Fergus Shanahan,Loren C. Karp Limited preview - 2007 |
Inflammatory Bowel Disease: From Bench to Bedside Stephan R. Targan,Fergus Shanahan,Loren C. Karp No preview available - 2003 |
Common terms and phrases
activity adhesion antibodies antigens apoptosis arthritis ASCA associated bacterial biopsies CD4+ T cells chemokines chronic clinical colectomy colon Crohn's disease crypt cytokines diagnosis diarrhea distal drug dysplasia effects endoscopic endothelial cells epithelial cells epithelium expression fistulas flora function Gastroenterology gastrointestinal gene genetic glucocorticoid growth factor HRQL human IBD patients IFN-y ileal immune response Immunol increased induced infection inflammation inflammatory bowel disease infliximab inhibition interactions interleukin intestinal epithelial cells intestinal inflammation involved lamina propria lesions leukocyte levels lymphocytes macrophages markers mechanisms mediated methotrexate mice molecules mucosal neutrophil normal oral pANCA pathogenesis pathogenic patients with IBD peptide pouchitis primary sclerosing cholangitis production proinflammatory protein rats reactive receptor rectal regulation risk role Scand J Gastroenterol serum small bowel small intestine specific studies sulfasalazine susceptibility Targan therapeutic therapy tion tissue transgenic treatment UC patients ulcerative colitis